Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Adriana Aurelia Chis"'
Autor:
Carmen Maximiliana Dobrea, Adina Frum, Anca Butuca, Claudiu Morgovan, Laurentiu Stoicescu, Adriana Aurelia Chis, Anca Maria Arseniu, Luca Liviu Rus, Felicia Gabriela Gligor, Andreea Loredana Vonica-Tincu
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1278 (2024)
As the most common psychiatric symptom, depression represents a subject of high interest for the medical community. Background/Objectives: International guidelines consider selective serotonin reuptake inhibitors (SSRIs) the first-line treatment of d
Externí odkaz:
https://doaj.org/article/fa0d43173c744a6dbe3ea8c6f9aa4035
Autor:
Adriana Aurelia Chis, Carmen Maximiliana Dobrea, Anca Maria Arseniu, Adina Frum, Luca-Liviu Rus, Gabriela Cormos, Cecilia Georgescu, Claudiu Morgovan, Anca Butuca, Felicia Gabriela Gligor, Andreea Loredana Vonica-Tincu
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 13, p 6969 (2024)
Antineoplastic therapy is one of the main research themes of this century. Modern approaches have been implemented to target and heighten the effect of cytostatic drugs on tumors and diminish their general/unspecific toxicity. In this context, antibo
Externí odkaz:
https://doaj.org/article/ac3db6e2112d42a4a1a9ea2f10a12525
Autor:
Anca Butuca, Carmen Maximiliana Dobrea, Anca Maria Arseniu, Adina Frum, Adriana Aurelia Chis, Luca Liviu Rus, Steliana Ghibu, Anca Maria Juncan, Andrei Catalin Muntean, Antonina Evelina Lazăr, Felicia Gabriela Gligor, Claudiu Morgovan, Andreea Loredana Vonica-Tincu
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 1124 (2024)
Some glucagon-like peptide-1 receptor agonists (GLP-1 RAs), first used in the treatment of type 2 diabetes mellitus (T2DM), have been approved for the treatment of obesity in patients with or without T2DM (liraglutide—LIR, semaglutide—SEM, and ti
Externí odkaz:
https://doaj.org/article/60e372e6d7a04b2cb306211f4336ffc2
Autor:
Claudiu Morgovan, Carmen Maximiliana Dobrea, Anca Butuca, Anca Maria Arseniu, Adina Frum, Luca Liviu Rus, Adriana Aurelia Chis, Anca Maria Juncan, Felicia Gabriela Gligor, Cecilia Georgescu, Steliana Ghibu, Andreea Loredana Vonica-Tincu
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 953 (2024)
Trastuzumab (T) and tyrosine kinase inhibitors (TKIs) are among the first-line treatments recommended for HER2-positive breast cancer. More recently, antibody-drug conjugates (ADCs) such as trastuzumab deruxtecan (T-DXd) and trastuzumab emtansine (T-
Externí odkaz:
https://doaj.org/article/fe19fbaefa09496e8020d882f4b68a84
Autor:
Ioana Maria Carmen Ienașcu, Adina Căta, Adriana Aurelia Chis, Mariana Nela Ştefănuț, Paula Sfîrloagă, Gerlinde Rusu, Adina Frum, Anca Maria Arseniu, Claudiu Morgovan, Luca Liviu Rus, Carmen Maximiliana Dobrea
Publikováno v:
Materials, Vol 16, Iss 8, p 2967 (2023)
Glucosinolates-rich extracts of some Brassicaceae sources, such as broccoli, cabbage, black radish, rapeseed, and cauliflower, were obtained using an eco-friendly extraction method, in a microwave field, with 70% ethanol, and evaluated in order to es
Externí odkaz:
https://doaj.org/article/41edc6f20b8e471289fb88e18ba3b296
Autor:
Claudiu Morgovan, Carmen Maximiliana Dobrea, Adriana Aurelia Chis, Anca Maria Juncan, Anca Maria Arseniu, Luca Liviu Rus, Felicia Gabriela Gligor, Simona Alexandrina Ardelean, Laurentiu Stoicescu, Steliana Ghibu, Adina Frum
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 455 (2023)
Direct oral anticoagulant drugs (DOACs) interfere with the coagulation process, thus improving patient care for those who require anticoagulant treatment. This study presents a descriptive analysis of adverse reactions (ADRs) attributed to DOAC dosag
Externí odkaz:
https://doaj.org/article/ba59d5a963694b66b559a6bb856d30eb
Autor:
Adriana Aurelia Chis, Anca Maria Arseniu, Claudiu Morgovan, Carmen Maximiliana Dobrea, Adina Frum, Anca Maria Juncan, Anca Butuca, Steliana Ghibu, Felicia Gabriela Gligor, Luca Liviu Rus
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1773 (2022)
Nowadays, cancer represents a major public health issue, a substantial economic issue, and a burden for society. Limited by numerous disadvantages, conventional chemotherapy is being replaced by new strategies targeting tumor cells. In this context,
Externí odkaz:
https://doaj.org/article/fa4c3287ffec4cb490f957785fd87cd6
Autor:
Adina Frum, Carmen Maximiliana Dobrea, Luca Liviu Rus, Lidia-Ioana Virchea, Claudiu Morgovan, Adriana Aurelia Chis, Anca Maria Arseniu, Anca Butuca, Felicia Gabriela Gligor, Laura Gratiela Vicas, Ovidiu Tita, Cecilia Georgescu
Publikováno v:
Nutrients, Vol 14, Iss 15, p 3065 (2022)
Grape pomace and berries represent natural sources of phytochemicals that can increase the quality of life of consumers by contributing to the prevention of chronic diseases; thus, the development of a dietary supplement was necessary. The raw materi
Externí odkaz:
https://doaj.org/article/dad4e4d8e24d4a6194ca94a75dda44a3
Autor:
Luca Liviu Rus, Anca Maria Juncan, Veronica Isabela Crăciun, Adina Frum, Simona-Codruța Hegheș, Anca Butuca, Carmen Maximiliana Dobrea, Adriana Aurelia Chis, Andrei Catalin Muntean, Andreea Loredana Vonica-Ţincu, Claudiu Morgovan
Publikováno v:
Applied Sciences, Vol 12, Iss 9, p 4476 (2022)
In this study, a spectrophotometric method for the quantitative determination of zinc in a dietary supplement was validated. Zinc forms a ternary complex with Xylenol Orange and cetylpyridinium chloride in acetate buffer at pH = 5.5. The complex exhi
Externí odkaz:
https://doaj.org/article/a9111aaa7ab44f7dbc4d81a6ffe3a444
Autor:
Adriana Aurelia Chis, Carmen Maximiliana Dobrea, Luca-Liviu Rus, Adina Frum, Claudiu Morgovan, Anca Butuca, Maria Totan, Anca Maria Juncan, Felicia Gabriela Gligor, Anca Maria Arseniu
Publikováno v:
Molecules, Vol 26, Iss 19, p 5976 (2021)
Gene-directed enzyme prodrug therapy (GDEPT) has been intensively studied as a promising new strategy of prodrug delivery, with its main advantages being represented by an enhanced efficacy and a reduced off-target toxicity of the active drug. In rec
Externí odkaz:
https://doaj.org/article/b2378bb4f9874f0ab2c23e5fd222d6af